Dr. John Hoekman is a proven biotech entrepreneur and executive. Previously, he was Co-founder, Chief Scientific Officer, and Chief Technology and Development Officer of Impel Pharmaceuticals. He invented the core technology for Impel during his PhD at University for Washington, spun out the company, built the team to 190 people, raised over $250MM, successfully IPO’d, and earned an FDA approval for Trudhesa. He is a co-inventor on over 100 patents. He holds a BS in Physics from the University of Minnesota and a PhD in Pharmaceutics from the University of Washington.